Cargando…
Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial)
BACKGROUND: Preterm birth is the most common cause of neonatal morbidity and mortality. Postponing delivery for 48 hours with tocolytics to allow for maternal steroid administration and antenatal transportation to a centre with neonatal intensive care unit facilities is the standard treatment for wo...
Autores principales: | van Vliet, Elvira OG, Schuit, Ewoud, Heida, Karst Y, Opmeer, Brent C, Kok, Marjolein, Gyselaers, Wilfried, Porath, Martina M, Woiski, Mallory, Bax, Caroline J, Bloemenkamp, Kitty WM, Scheepers, Hubertina CJ, Jaquemyn, Yves, van Beek, Erik, Duvekot, Hans JJ, Franssen, Maureen TM, Bijvank, Bas N, Kok, Joke H, Franx, Arie, Mol, Ben Willem J, Oudijk, Martijn A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944539/ https://www.ncbi.nlm.nih.gov/pubmed/24589124 http://dx.doi.org/10.1186/1471-2393-14-93 |
Ejemplares similares
-
Effects of tocolysis with nifedipine or atosiban on child outcome: follow‐up of the APOSTEL III trial
por: van Winden, TMS, et al.
Publicado: (2020) -
Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial)
por: Roos, Carolien, et al.
Publicado: (2009) -
Tocolysis with nifedipine versus atosiban and perinatal outcome: an individual participant data meta-analysis
por: van Winden, Tijn M. S., et al.
Publicado: (2022) -
Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study
por: Klumper, Job, et al.
Publicado: (2019) -
Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial)
por: Vis, Jolande Y, et al.
Publicado: (2009)